Bremer S - Search Results

1

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.

Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S. Bremer S, et al. J Transl Med. 2009 Jul 27;7:64. doi: 10.1186/1479-5876-7-64. J Transl Med. 2009. PMID: 19635156 Free PMC article.

2

Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells.

Bremer S, Rootwelt H, Bergan S. Bremer S, et al. Clin Chem. 2007 Jun;53(6):1023-9. doi: 10.1373/clinchem.2006.081968. Epub 2007 Apr 26. Clin Chem. 2007. PMID: 17463174

3

Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.

Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S. Bremer S, et al. Transplantation. 2008 Jan 15;85(1):55-61. doi: 10.1097/01.tp.0000296854.68123.03. Transplantation. 2008. PMID: 18192912

4

Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.

Vethe NT, Bremer S, Rootwelt H, Bergan S. Vethe NT, et al. Among authors: bremer s. Ther Drug Monit. 2008 Dec;30(6):647-55. doi: 10.1097/FTD.0b013e31818955c3. Ther Drug Monit. 2008. PMID: 18806697 Clinical Trial.

5

Expression of IMPDH1 is regulated in response to mycophenolate concentration.

Bremer S, Vethe NT, Rootwelt H, Bergan S. Bremer S, et al. Int Immunopharmacol. 2009 Feb;9(2):173-80. doi: 10.1016/j.intimp.2008.10.017. Epub 2008 Nov 20. Int Immunopharmacol. 2009. PMID: 19010451

6

Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation.

Sæves I, Line PD, Bremer S, Vethe NT, Tveit RG, Meltevik TJ, Bergan S. Sæves I, et al. Among authors: bremer s. Ther Drug Monit. 2014 Feb;36(1):46-53. doi: 10.1097/FTD.0b013e31829dcb66. Ther Drug Monit. 2014. PMID: 24081206 Clinical Trial.

7

Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective Study.

Skauby RH, Bjerre A, Sæves I, Vethe NT, Bremer S, Svarstad A, Bergan S. Skauby RH, et al. Among authors: bremer s. Ther Drug Monit. 2017 Oct;39(5):472-482. doi: 10.1097/FTD.0000000000000439. Ther Drug Monit. 2017. PMID: 28749817

8

IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.

Vethe NT, Bremer S, Bergan S. Vethe NT, et al. Among authors: bremer s. Scand J Clin Lab Invest. 2008;68(4):277-85. doi: 10.1080/00365510701724871. Scand J Clin Lab Invest. 2008. PMID: 18609073

9

Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients.

Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K. Falck P, et al. Among authors: bremer s. Transplantation. 2008 Nov 27;86(10):1379-83. doi: 10.1097/TP.0b013e31818aa4b6. Transplantation. 2008. PMID: 19034006

10

Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.

Vethe NT, Ali AM, Reine PA, Andersen AM, Bremer S, Line PD, Rootwelt H, Bergan S. Vethe NT, et al. Among authors: bremer s. Ther Drug Monit. 2014 Feb;36(1):108-18. doi: 10.1097/FTD.0b013e3182a13900. Ther Drug Monit. 2014. PMID: 24061448 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters